Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease  by Palop, Jorge J. et al.
Neuron
ArticleAberrant Excitatory Neuronal Activity and
CompensatoryRemodelingof InhibitoryHippocampal
Circuits in Mouse Models of Alzheimer’s Disease
Jorge J. Palop,1,3,* Jeannie Chin,1,3 Erik D. Roberson,1,3 Jun Wang,1,3 Myo T. Thwin,1 Nga Bien-Ly,1,2 Jong Yoo,6
Kaitlyn O. Ho,1 Gui-Qiu Yu,1 Anatol Kreitzer,1,2,3,4,5 Steven Finkbeiner,1,2,3,4,5 Jeffrey L. Noebels,6
and Lennart Mucke1,2,3,5,*
1Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA




University of California, San Francisco, San Francisco, CA 94158, USA
6Developmental Neurogenetics Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA
*Correspondence: lmucke@gladstone.ucsf.edu (L.M.), jpalop@gladstone.ucsf.edu (J.J.P.)
DOI 10.1016/j.neuron.2007.07.025SUMMARY
Neural network dysfunction may play an impor-
tant role in Alzheimer’s disease (AD). Neuronal
circuits vulnerable to AD are also affected in
human amyloid precursor protein (hAPP) trans-
genic mice. hAPP mice with high levels of
amyloid-b peptides in the brain develop AD-
like abnormalities, including cognitive deficits
and depletions of calcium-related proteins in
the dentate gyrus, a region critically involved
in learning and memory. Here, we report that
hAPP mice have spontaneous nonconvulsive
seizure activity in cortical and hippocampal
networks, which is associated with GABAergic
sprouting, enhanced synaptic inhibition, and
synaptic plasticity deficits in the dentate gyrus.
Many Ab-induced neuronal alterations could
be simulated in nontransgenic mice by excito-
toxin challenge and prevented in hAPP mice
by blocking overexcitation. Aberrant increases
in network excitability and compensatory inhib-
itory mechanisms in the hippocampus may
contribute to Ab-induced neurological deficits
in hAPP mice and, possibly, also in humans
with AD.
INTRODUCTION
The hippocampus plays key roles in learning and memory
(Burgess et al., 2002; Frankland and Bontempi, 2005;
Morris et al., 1982; O’Keefe et al., 1975) and is a prime tar-
get of Alzheimer’s disease (AD), which causes progressive
memory impairments (Blennow et al., 2006). Although
much is known about the neural circuits and molecularNepathways required for normal hippocampal functions,
the processes by which AD disables this brain region re-
main to be defined. We recently postulated that destabili-
zation of neuronal network activity may contribute to cog-
nitive impairments associated with AD and hypothesized
that such destabilization may result, at least in part, from
aberrant alterations in neuronal network activity and
resulting compensatory responses (Palop et al., 2006).
A key molecule that may perturb network activity in AD is
the amyloid-b (Ab) peptide, which is derived from the am-
yloid precursor protein (APP) by proteolytic cleavage.
The excessive accumulation of pathogenic Ab assemblies
in the brain appears to play a causal role in AD (Glenner and
Wong, 1984; Tanzi and Bertram, 2005; Walsh and Selkoe,
2004). In strong support of this notion, neuronal expression
of human APP (hAPP) and Ab in transgenic mice elicits sev-
eral AD-like abnormalities, including amyloid plaques,
neuritic dystrophy, aberrant sprouting of axon terminals,
functional and structural synaptic deficits, impairments in
learning and memory, and other behavioral alterations
(Chin et al., 2004, 2005; Games et al., 1995; Go¨tz et al.,
2004; Kobayashi and Chen, 2005; Palop et al., 2003, 2005).
The relevance of these transgenic mouse models to the
human condition is further underlined by the fact that their
impairments do not affect the entire brain but primarily
those regions that are particularly vulnerable to AD, in-
cluding the hippocampus. Ab-dependent deficits in hip-
pocampal learning and memory correlate well with alter-
ations in calcium- and synaptic activity-related proteins
in granule cells of the dentate gyrus (Chin et al., 2005;
Palop et al., 2003, 2005), a brain region critically involved
in learning and memory (Singer et al., 2005). These func-
tionally relevant molecular alterations include reductions
in the calcium-binding protein calbindin-D28K, the immedi-
ate-early gene products Arc and Fos, the dendritic spine
actin-binding protein a-actinin-II, and the phosphorylation
states of the NMDA receptor subunit NR2B and the MAP
kinases ERK1/2, as well as increases in the a7 nicotinicuron 55, 697–711, September 6, 2007 ª2007 Elsevier Inc. 697
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The levels of these molecules are affected to different de-
grees in different familial AD mutant hAPP (hAPPFAD) mice
but to very similar degrees in any given hAPPFAD mouse,
suggesting a common underlying mechanism (Chin
et al., 2005; Palop et al., 2003, 2005).
Notably, several of these dentate alterations have also
been observed in humans with AD (Palop et al., 2003), hu-
mans with epilepsy (Na¨gerl et al., 2000), and animal mo-
dels with chronic aberrant increases in excitatory neuronal
activity (overexcitation; Marksteiner et al., 1990; Peng and
Houser, 2005; Tonder et al., 1994a, 1994b). These findings
suggest that the dentate alterations of hAPPFAD mice and
humans with AD may be caused, at least in part, by aber-
rant increases in neuronal activity, consistent with the in-
creased risk of seizure activity in sporadic and familial
AD and with the excitotoxicity hypothesis of neurodegen-
erative disorders (for review, Amatniek et al., 2006; Mark
et al., 1995; Mattson et al., 1993; Olney, 1995; Rothman
and Olney, 1995; Snider et al., 2005). However, Ab de-
creases glutamatergic synaptic transmission, at least at
certain synapses, presumably through a mechanism that
involves the endocytosis of AMPA receptors and subse-
quent collapse of dendritic spines (Hsia et al., 1999; Hsieh
et al., 2006; Kamenetz et al., 2003; Shankar et al., 2007;
Walsh et al., 2002). Therefore, the depletion of calcium-
and synaptic activity-related proteins in the dentate gyrus
of hAPPFAD mice may also be caused by the suppression
of overall network activity. Because Ab might act differen-
tially on neuronal subtypes and brain regions, it is unclear
whether the net effect of Ab on specific networks is excit-
atory, inhibitory, or combines elements of both.
To explore whether Ab-dependent neuronal alterations
associated with cognitive deficits are more closely related
to overexcitation or suppression of neuronal activity in
cortical and hippocampal networks, we analyzed four
lines of transgenic mice expressing FAD mutant or wild-
type (WT) hAPP. Compared with nontransgenic (NTG)
mice and with hAPPWT transgenic mice, hAPPFAD mice
with high levels of Ab showed anatomical and biochemical
alterations in the dentate gyrus that are indicative of aber-
rant excitatory neuronal activity. Electroencephalographic
(EEG) recordings in hAPPFAD mice revealed intermittent
epileptiform cortical and hippocampal synchronous dis-
charges and generalized nonconvulsive seizure activity.
These abnormalities were associated with a prominent re-
modeling of inhibitory circuits, increased synaptic inhibi-
tion, and synaptic plasticity deficits in the dentate gyrus.
Many of these alterations could be simulated in NTG
mice by systemic injection with kainate and prevented in
both hAPPFAD mice and kainate-treated NTG mice by re-
moval of Tau, a genetic manipulation that protects against
excitotoxin-induced seizure activity (Roberson et al.,
2007). Our data demonstrate that hAPP/Ab induces aber-
rant excitatory neuronal network activity in vivo and trig-
gers compensatory inhibitory mechanisms in hippocam-
pal circuits. Both the aberrant excitatory neuronal
activity and the compensatory inhibitory mechanisms698 Neuron 55, 697–711, September 6, 2007 ª2007 Elsevier Inmay limit the capacity for synaptic plasticity and contrib-
ute to AD-related network dysfunction.
RESULTS
Remodeling of Neuronal Circuits
in the Dentate Gyrus
Axonal sprouting of GABAergic interneurons and alter-
ations in the expression of neuropeptide Y (NPY) are sen-
sitive indicators of imbalances between excitatory and
inhibitory neuronal activities in the hippocampus (for re-
view, Vezzani et al., 1999). Compared with NTG controls,
hAPPFAD mice from the high expresser J20 line (hAPP-J20
mice) showed ectopic expression of NPY in the molecular
layer of the dentate gyrus and in the axons of granule cells
(mossy fibers; Figure 1A). Double labeling for NPY and cal-
bindin revealed that these alterations were associated
with depletions of calbindin in granule cells (Figures 1B–
1D), which correlate with deficits in learning and memory
in this model and are also seen in humans with AD (Palop
et al., 2003). Compared with NTG controls, hAPP-J20
mice showed a marked increase in NPY mRNA levels in
granule cells (Figure 1E), suggesting that the ectopic pres-
ence of NPY in mossy fibers was caused by increased
NPY gene expression in these neurons. In contrast, the
NPY-positive sprouting in the molecular layer more likely
emanated from hilar NPY- and somatostatin (SOM)-
positive GABAergic interneurons (Bakst et al., 1986;
Freund and Buzsa´ki, 1996; Vezzani et al., 1999), since
these fibers were also immunoreactive for somatostatin
(Figures 1F and 1G) and failed to stain with the Timm
method, which detects the high levels of zinc present in
mossy fibers (data not shown). Because NPY- and
SOM-positive GABAergic hilar interneurons inhibit the
dendrites of granule cells (Freund and Buzsa´ki, 1996),
the inhibitory sprouting would be expected to increase in-
hibition of granule cells. Dentate mRNA levels for NPY-Y1
and -Y2 receptors were determined by quantitative fluoro-
genic RT-PCR. Compared with NTG mice, the mRNA level
for Y1 receptors, which exert weak excitatory activity of
NPY (Vezzani et al., 1999), was decreased in hAPP-J20,
whereas the mRNA level for Y2 receptors, which mediate
potent inhibitory activity of NPY (Vezzani et al., 1999), was
increased (Figure 1H).
To exclude the possibility that the NPY alterations in
hAPP-J20 mice resulted from hAPP overexpression or
from a transgene insertion effect, we analyzed additional
hAPPWT (hAPP-I5) and hAPPFAD (hAPP-ARC48 and hAPP-
J9/FYN) transgenic lines (Cheng et al., 2004, 2007; Chin
et al., 2004, 2005; Mucke et al., 2000). NPY expression
in hAPP-I5 mice, which have similar hAPP levels as
hAPP-J20 mice but much lower levels of Ab, was indistin-
guishable from that in NTG controls (see Figure S1A in the
Supplemental Data available with this article online),
excluding a direct effect of hAPP overexpression on these
alterations. The two additional hAPPFAD lines showed prom-
inent increases in NPY expression (Figures S1B–S1E),c.
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cuits and Alterations in the Expression
of NPY and Its Receptors in the Dentate
Gyrus of hAPP-J20 Mice
(A) Brain sections were immunoperoxidase-
stained for NPY. Compared with NTG controls,
hAPP-J20 mice had an increase in NPY ex-
pression in the molecular layer of the dentate
gyrus (arrow) and in the mossy fibers (arrow-
head).
(B) Confocal microscopic imaging of sections
double-labeled for calbindin (red) and NPY
(green) demonstrated sprouting of NPY axons
in the molecular layer (arrow), ectopic expres-
sion of NPY in mossy fibers (arrowheads),
and severe depletion of calbindin (CB) in gran-
ule cells of an hAPP-J20 mouse. Images repre-
sent the regions indicated by squares in (A).
(C and D) Calbindin depletions correlated with
NPY increases in the dentate gyrus (C) and
mossy fibers (D) in hAPP-J20 mice.
(E) In situ hybridization revealed ectopic ex-
pression of NPY mRNA in granule cells (arrow)
of an hAPP-J20 mouse (bottom panel).
(F) Compared with NTG mice, hAPP-J20 mice
had sprouting of somatostatin (SOM)-positive
axons in the molecular layer (top panels), which
was quantitated by densitometry (bottom
panel).
(G) Axonal sprouts in the molecular layer of
hAPP-J20 mice were double-labeled for NPY
(green) and SOM (red), indicating that they
originated from hilar GABAergic cells.
(H) NPY receptors in the dentate gyrus were
also altered in hAPP-J20 mice, as determined
by quantitative fluorogenic RT-PCR: the mRNA
for Y1 receptors was decreased, whereas the
mRNA for Y2 receptors was increased com-
pared with NTG controls. Numbers in bars indi-
cate number of mice per group.
*p < 0.05, **p < 0.01, ***p < 0.001 versus NTG
by Student’s t test. Quantitative data represent
mean ± SEM.demonstrating that this alteration is not restricted to
hAPP-J20 mice.
Ectopic expression of NPY in mossy fibers has previ-
ously been identified in aged hAPPFAD mice and was as-
cribed to late amyloid deposition (Diez et al., 2000,
2003). However, we found that the magnitude of NPY ele-
vation was similar in the three independent hAPPFAD lines,
even though they have vastly different plaque loads
(Figure S1F and Cheng et al., 2004; Chin et al., 2005; Palop
et al., 2003). Thus, it is very likely that NPY and calbindin
alterations in hAPPFAD mice are unrelated to amyloid
deposition.
Circuit Alterations that Distinguish hAPPFAD Mice
from Epilepsy Models
The GABAergic sprouting and NPY alterations we identi-
fied in different hAPPFAD lines have also been observed
in animal models with chronic epilepsy and aberrant in-
creases in neuronal activity (for review, Vezzani et al.,Ne1999). We therefore examined whether hAPP-J20 mice
resemble epilepsy models also with respect to circuit
alterations that are widely presumed to promote epilepto-
genesis: recurrent excitatory sprouting of collateral mossy
fibers in the inner molecular layer and loss of inhibitory in-
terneurons in the hilus (Cobos et al., 2005; de Lanerolle
et al., 1989; Mathern et al., 1995). We found no evidence
for recurrent mossy fiber sprouting in the inner molecular
layer of hAPP-J20 mice either by NPY immunostaining
(Figures 1 A and 1B) or by Timm staining (Figure 2A). In-
stead, there was an increase of collateral mossy fibers
crossing the granule cell layer (Figures 2A and 2B). Double
labeling for collateral mossy fibers (Timm) and markers of
GABAergic basket cells (parvalbumin or NPY) revealed
that the Timm-positive sprouting was specifically and
heavily decorating somas and proximal dendrites of
basket cells (Figure 2C). Because the GABAergic basket
cells inhibit the granule cells (Freund and Buzsa´ki, 1996),
increased excitatory mossy fiber innervation of basketuron 55, 697–711, September 6, 2007 ª2007 Elsevier Inc. 699
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cells. In a similar vein, quantification of the number of
somatostatin-positive interneurons in the hilus throughout
the rostrocaudal extent of the hippocampus showed no
significant difference between NTG and hAPP-J20 mice
Figure 2. Aberrant Innervation of Inhibitory Basket Cells by
Glutamatergic Mossy Fiber Collaterals
Brain sections from hAPP-J20 and NTG mice were stained with the
Timm method to detect glutamatergic synaptic vesicles in collateral
mossy fibers and/or immunostained for the GABAergic basket cell
markers parvalbumin (PV) or NPY.
(A) Sprouting of mossy fiber collaterals in the dentate gyrus was evi-
dent in hAPP-J20 mice but not in the NTG controls. Note the increase
of Timm-positive axons in the granular layer (arrow) and the Timm-
positive clusters in the inner molecular layer (arrowhead) of the
hAPP-J20 mouse.
(B) Quantitation of Timm-positive collateral mossy fibers in the granular
layer of hAPP-J20 and NTG mice.
(C) Collateral mossy fibers outlined specific cells in the granular layer of
hAPP-J20 mice (left). Double labeling for Timm/PV (center) or Timm/
NPY (right) identified these cells as basket cells.
(D) Somatostatin (SOM)-positive GABAergic interneurons (arrow) in the
hilus of the dentate gyrus in an hAPP-J20 mouse and a NTG control.
(E) Quantitation of SOM-positive interneurons in the hilus. Data repre-
sent the mean (±SEM) number of cells at different rostrocaudal levels.
**p < 0.01 versus NTG by Student’s t test. Quantitative data represent
mean ± SEM.700 Neuron 55, 697–711, September 6, 2007 ª2007 Elsevier In(Figures 2D and 2E). Thus, the dentate gyrus of hAPP-
J20 mice exhibits circuit alterations that are widely pre-
sumed to enhance inhibition but lacks those that promote
hippocampal epileptogenesis, suggesting an incomplete
mechanistic overlap with models of epilepsy.
Increased Inhibition in Granule Cells
of hAPP-J20 Mice
In models of epilepsy, synaptic inhibition in the dentate
gyrus is compromised primarily due to the loss of hilar
NPY- and SOM-positive GABAergic cells (Kobayashi
and Buckmaster, 2003; Shao and Dudek, 2005). To test
whether the remodeling of inhibitory hippocampal circuits
in hAPP-J20 mice is associated with increased inhibition
in granule cells, we performed whole-cell voltage-clamp
recordings to isolate miniature inhibitory postsynaptic cur-
rents (mIPSCs). We found that the frequency of mIPSCs
recorded from dentate granule cells was significantly in-
creased in hAPP-J20 mice relative to NTG controls (Fig-
ures 3A–3C). Although mIPSC amplitudes were not signif-
icantly different between NTG and hAPP-J20 mice when
all events were averaged (data not shown), the cumulative
probability plot demonstrated that large-amplitude events
were enhanced in hAPP-J20 mice (Figure 3D). When the
largest 25% of events were averaged, there was a signifi-
cant difference in mIPSC amplitude between NTG and
hAPP-J20 mice (Figure 3E). The increases in mIPSC fre-
quency and large-amplitude events observed in granule
cells of hAPP-J20 mice suggest an increase in the number
of functional GABAergic synapses onto the granule cells
and may reflect enhanced presynaptic GABA release,
enhanced postsynaptic GABA sensitivity, or both.
Pharmacological Induction of Neuronal
Overexcitation in NTG Mice Triggers Molecular
and Anatomical Alterations Resembling Those
Observed in Untreated hAPP-J20 Mice
The circuit alterations we identified in the dentate gyrus of
hAPPFAD mice may be typical responses of hippocampal
networks to aberrant increases in neuronal activity. To be-
gin to address this possibility, we used the excitatory
amino acid kainate to elicit aberrant increases in neuronal
activity in NTG mice. Three days after receiving an intra-
peritoneal (i.p.) injection of kainate or saline, NTG mice
were analyzed for a number of neuronal alterations known
to be present in untreated hAPP-J20 mice and hAPP-J9/
FYN mice (this study and Chin et al., 2005; Palop et al.,
2003, 2005). Kainate-treated NTG mice showed dose-
dependent increases in NPY and depletions of Arc-
positive granule cells in the dentate gyrus (Figures 4A–
4D). Levels of STEP, a7 nAchR, and calbindin (Figure 4E)
were also altered in the same direction as in untreated
hAPP-J20 and hAPP-J9/FYN mice (Chin et al., 2005).
Thus, an excitotoxin challenge was sufficient to trigger in
NTG mice many of the alterations observed in the dentate
gyrus of hAPPFAD mice at baseline.
Interestingly, systemic injection of kainate (25 mg/kg) or
of the muscarinic receptor agonist pilocarpine (250 mg/kg)c.
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and Large-Amplitude mIPSCs in Dentate
Gyrus Slices from hAPP-J20 Mice
(A) Representative traces of mIPSCs recorded
from NTG (top) and hAPP-J20 (bottom) mice.
(B) Average cumulative probability plot of
mIPSC interevent intervals for NTG (thin line,
n = 7 cells, 3 mice) and hAPP-J20 (thick line,
n = 10 cells, 3 mice) mice shows decreased in-
terevent intervals in hAPP-J20 mice.
(C) mIPSC frequency was significantly in-
creased in hAPP-J20 mice (NTG, n = 7 cells,
3 mice; hAPP-J20, n = 10 cells, 3 mice).
(D) Average cumulative probability plot of
mIPSC amplitudes recorded from NTG (thin
line, n = 7 cells, 3 mice) and hAPP-J20 (thick
line, n = 10 cells, 3 mice) mice shows enhanced
number of large-amplitude mIPSCs.
(E) The largest 25% of mIPSCs were increased
in amplitude in the hAPP-J20 mice. (n = 10
cells, 3 mice) relative to NTG controls (n = 7
cells, 3 mice). *p < 0.05 by Student’s t test.
Quantitative data represent mean ± SEM.elicited tonic-clonic seizure activity of comparable sever-
ity (Figure 4F) in NTG mice, but only kainate led to an in-
crease in NPY expression (Figure 4G), suggesting that
seizure activity per se was not sufficient to alter NPY
expression. To assess whether particular patterns of neu-
ronal activation may be required to increase NPY expres-
sion, we analyzed Arc expression 2 hr after the treatments.
Although both kainate and pilocarpine acutely increased
neuronal Arc expression in the neocortex, only kainate in-
creased Arc expression in granule cells (Figure 4H). Thus,
overexcitation of granule cells may be required to trigger
the aberrant NPY expression in the dentate gyrus.
Tau Reduction Prevents Kainate-
and hAPP/Ab-Induced Changes in NPY
Genetic reduction of the microtubule-binding protein tau
diminished the susceptibility of hAPP-J20 and NTG mice
to seizures induced by kainate or the GABAA receptor
antagonist pentylenetetrazole (PTZ), and ameliorated Ab-
dependent cognitive deficits in hAPP-J20 mice (Roberson
et al., 2007). We therefore examined whether the kainate-
or Ab-induced alterations described above could also be
prevented by tau reduction. After i.p. injection with kainate
(17 mg/kg), seizures were less severe in Tau/ mice than
in Tau+/+ mice (Figure 5A), as described (Roberson et al.,
2007). Three days after the injection, brains were analyzed
for NPY expression. Tau removal effectively prevented kai-
nate-induced NPY increases in the dentate gyrus and
mossy fibers (Figure 5B). In untreated hAPP-J20 mice,
tau reduction dose dependently prevented NPY increases
(Figures 5C–5E) and calbindin depletions (Figures 5F and
5G). The observations that Ab and excitotoxins elicit simi-
lar molecular and anatomical alterations and that these
alterations can be prevented by the same genetic manip-
ulation suggest mechanistic overlap and support the hy-
pothesis that Ab promotes neuronal overexcitation.NeAb-Dependent Alterations in the Dentate Gyrus
Are Associated with Increased Seizure Activity
after Inhibition of GABAA Receptors
To test this hypothesis more directly, we assessed the
propensity of hAPPFAD mice and NTG controls to develop
seizures after systemic challenge with PTZ. After i.p. injec-
tion with PTZ, hAPP-J20 mice had earlier and more severe
seizures than NTG controls (Figure 6A). Seizure-induced
death was more frequent in hAPP-J20 mice than in NTG
controls (Figure 6A). hAPP-ARC48 mice and hAPP-J9/
FYN mice were also more susceptible to PTZ-induced sei-
zures than controls (Figures 6B and 6C). These findings
are consistent with results obtained in another line of
hAPP mice (Del Vecchio et al., 2004) and suggest that
chronic exposure to high levels of Ab sensitizes at least
some neuronal networks to overexcitation.
Interestingly, 50% of the hAPP-J20 mice developed fa-
tal status epilepticus after PTZ administration, whereas
the other 50% did not (Figure 6A, right panel). To test
whether this difference was related to molecular alter-
ations in the dentate gyrus, we first confirmed that the
levels of the proteins we wanted to analyze would not
be affected by acute fatal seizure activity during the
20 min duration of this experiment. NPY, calbindin, and
Fos levels in the dentate gyrus were not altered in NTG
mice that died acutely from a PTZ-induced seizure or
that survived for 20 min after PTZ-induced seizures (Fig-
ures 6D–6G), suggesting that the levels of these proteins
reflect the baseline situation even when analyzed after
acute seizures. hAPP-J20 mice that developed fatal sei-
zures after PTZ injection had greater increases in NPY
and more severe depletions of calbindin, Fos, and Arc
than hAPP-J20 mice with less-severe seizures and NTG
controls (Figures 6H–6K). Thus, the magnitude of these
molecular alterations likely reflects the severity of Ab-
induced increases in network excitability.uron 55, 697–711, September 6, 2007 ª2007 Elsevier Inc. 701
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tion in NTG Mice Triggers Molecular and Anatomical Alter-
ations Resembling Those Observed in Untreated hAPPFAD
Mice
(A–E) NTG mice were injected i.p. with saline (Sal) or kainate (KA) (5, 10,
20, or 25 mg/kg) and analyzed 3 days later. (A) Representative photo-
micrographs depicting KA-induced sprouting of NPY-positive termi-
nals in the molecular layer of the dentate gyrus (arrow) and ectopic ex-
pression of NPY in the mossy fibers (arrowhead). (B) Quantitation of
KA-induced increases in NPY expression demonstrating dose-depen-
dence. (C) Typical KA-induced reduction of Arc expression in granule
cells of the dentate gyrus. (D) This effect was also dose-dependent. (E)
Representative western blots of dentate lysates and quantitations of
signals, illustrating KA-induced changes in the levels of STEP (left),
a7 nAchR (center), and calbindin (right). Each lane represents an indi-
vidual mouse.
(F–H) NTG mice were injected i.p. with pilocarpine (Pilo) (250 mg/kg) or
kainate (25 mg/kg) and euthanized 2 hr or 3 days later for analysis of
NPY and Arc expression. (F) At these concentrations, both drugs eli-
cited similar overall seizure severity within 20 min after their injections.702 Neuron 55, 697–711, September 6, 2007 ª2007 Elsevier InIn Vivo EEG Recordings Revealed
Hyperexcitability and Nonconvulsive Seizure
Activity in hAPP-J20 Mice
To more directly test whether aberrant neuronal activity is
present in hAPP-J20 mice, we performed prolonged
video-EEG monitoring of six freely behaving hAPP-J20
adult mice (aged 3–7 months). In all hAPP-J20 mice, the
cortical background activity showed very frequent
(5–50/min), generalized, sharp, synchronous discharges
in all cortical electrodes throughout the monitoring period
that were never seen in NTG controls (Figure 7A). When
depth electrodes were bilaterally implanted in the hippo-
campus of two hAPP-J20 mice, similar high amplitude
discharges could occasionally be recorded even unilater-
ally (Figure 7B). These results demonstrate hippocampal
hyperexcitability and suggest the involvement of hippo-
campal networks in the aberrant generalized neocortical
synchronization.
In contrast to NTG controls, hAPP-J20 mice also exhi-
bited intermittent non-convulsive electroencephalogra-
phic seizures. This activity typically started with general-
ized spike and slow-wave discharges, which gradually
increased in frequency to a rapid spike discharge and
then decelerated to slow (1–2/s) spike-wave rhythms, fol-
lowed by an abrupt termination of the ictal event with pro-
nounced cortical EEG depression (Figure 7C). During
these electroencephalographic seizures, the mice were
immobile, showing no visible myoclonic activity. When
the postictal EEG depression ended, they resumed nor-
mal exploratory behaviors (data not shown).
Aberrant Arc Expression in Granule Cells
of hAPPFAD Mice
To assess whether spontaneous episodes of neuronal
overexcitation could also be detected by gene expression
imaging (Link et al., 1995; Lyford et al., 1995), we analyzed
Arc expression in a large number of untreated mice to
broadly profile neuronal activity patterns. In the majority
of hAPP-J20 mice, Arc expression in granule cells was
much lower than in NTG controls (Figures 8A and 8B),
consistent with previous findings (Palop et al., 2005).
However, 13 of 151 untreated hAPP-J20 mice (8.6%)
had markedly increased Arc expression in granule cells
(Figure 8C). This abnormal pattern of Arc expression was
not found in any of the 135 NTG controls and likely reflects
a recent episode of abnormal overexcitation (Link et al.,
1995; Lyford et al., 1995; Palop et al., 2006). hAPP-J20
mice with increased Arc expression had even higher
NPY levels and lower calbindin levels than hAPP-J20
mice with reduced Arc expression (Figures 8D and 8E).
(G) By 3 days after the injection, KA, but not pilocarpine, increased
NPY expression in mossy fibers. (H) By 2 hr after the injection, both
drugs elicited comparable increases in Arc expression in the neocor-
tex, but only KA elicited marked Arc expression in granule cells.
#p < 0.05, ##p < 0.01, ###p < 0.001 by ANOVA and contrasts test.
*p < 0.05, **p < 0.01, ***p < 0.001 versus Sal by Student’s t test or
Tukey-Kramer test. Quantitative data represent mean ± SEM.c.
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in the Dentate Gyrus of hAPP-J20 Mice
Alterations in NMDA and AMPA glutamate receptors have
been linked to Ab-induced impairments in synaptic plas-
ticity and the collapse of dendritic spines (Hsieh et al.,
2006; Kamenetz et al., 2003; Shankar et al., 2007). To
test whether hAPP-J20 mice exhibit alterations in gluta-
mate receptors, we examined the phosphorylation state
of tyrosine residue 1472 of the NR2B subunit of NMDARs,
which modulates calcium conductance, is associated
Figure 5. Tau Reduction Prevents KA- and hAPP/Ab-Induced
Changes in NPY
(A and B) Tau/ and Tau+/+ mice were injected i.p. with saline or
17 mg/kg of kainate (KA), and brains were analyzed 3 days later. (A)
Compared with Tau+/+ mice, Tau/ mice displayed less KA-induced
freezing. (B) In Tau+/+ mice, but not in Tau/ mice, KA induced robust
increases in NPY in the dentate gyrus (left) and the mossy fibers (right).
(C–G) Brain sections from hAPP-J20 mice with or without Tau expres-
sion were immunostained for calbindin or NPY; immunoreactivity was
quantified by densitometry. (C) Increased NPY expression was prom-
inent in hAPP-J20/Tau+/+ mice, but absent in hAPP-J20/Tau/ mice.
(D and E) Quantitation of NPY-IR in the molecular layer (D) (hAPP x Tau
interaction, p < 0.02; ***p < 0.001, **p < 0.01 versus groups with-
out hAPP) and mossy fibers (E) (hAPP x Tau interaction, p < 0.02;
**p < 0.01 versus groups without hAPP). (F) Calbindin depletion in
the dentate gyrus was observed in hAPP-J20/Tau+/+ mice, but not in
hAPP-J20/Tau/ mice. (G) Quantitation of calbindin immunoreactivity
(CB-IR) in the molecular layer (hAPP x Tau interaction, p < 0.0001;
***p < 0.001 versus groups without hAPP.)
Quantitative data represent mean ± SEM.Newith long-term potentiation (LTP) induction, and controls
internalization of the receptor (reviewed in Salter and
Kalia, 2004). Levels of tyrosine-phosphorylated NR2B in
the dentate gyrus were lower in hAPP-J20 mice than in
NTG controls, whereas total levels of NR2B were un-
changed (Figure 8F; Palop et al., 2005). We also examined
AMPAR subunits GluR1 and GluR2, whose synaptic local-
ization is decreased by Ab (Almeida et al., 2005; Hsieh
et al., 2006; Snyder et al., 2005). Dentate levels of GluR1
and GluR2 were lower in hAPP-J20 mice than in NTG con-
trols (Figure 8G).
Short- and Long-Term Plasticity Impairments
in the Dentate Gyrus of hAPP-J20 Mice
As illustrated by this and previous studies (Chin et al.,
2005; Palop et al., 2003, 2005), neuronal circuits in the
dentate gyrus are exquisitely vulnerable to Ab-induced
molecular and anatomical alterations. To further assess
how these alterations may relate to synaptic dysfunction,
we performed field EPSPs recordings in hippocampal sli-
ces from the dentate gyrus and CA1 region. Perforant
pathway to granule cell synapses displayed severe im-
pairments in LTP and alterations in paired-pulse modifica-
tion (Figures 9A and 9B), but normal synaptic transmission
strength (Figure 9C), consistent with results obtained in
other hAPP models (Chapman et al., 1999). Analysis of
the Schaffer collateral to CA1 pyramidal cell synapse re-
vealed an opposite pattern of deficits, consistent with
our original observations in the CA1 region of two other
hAPPFAD lines (H6 and J9) (Hsia et al., 1999) and subse-
quent findings by others (Fitzjohn et al., 2001). LTP and
paired-pulse facilitation were normal (Figures 9D and
9E), whereas synaptic transmission strength was reduced
(Figure 9F). Thus, marked brain region-specific deficits
also exist at the electrophysiological level, and the dentate
gyrus appears to be particularly vulnerable to impairments
in both short- and long-term plasticity.
DISCUSSION
Our study demonstrates that hAPPFAD mice with high Ab
levels have spontaneous nonconvulsive seizure activity
in cortical and hippocampal networks, indicating that the
net effect of Ab on these networks is excitatory. AD pa-
tients also have a higher incidence of seizures than refer-
ence populations (Amatniek et al., 2006; Hauser et al.,
1986; Hesdorffer et al., 1996; Lozsadi and Larner, 2006;
Mendez and Lim, 2003). Interestingly, the risk of epileptic
activity is particularly high in AD patients with early-onset
dementia and during the earlier stages of the disease,
reaching an 87-fold increase in seizure incidence com-
pared with an age-matched reference population (Ama-
tniek et al., 2006; Mendez et al., 1994). Thus, aberrant neu-
ronal overexcitation may play an important role not only in
hAPPFAD mouse models, but also in the pathogenesis of
dementia in sporadic AD. Indeed, epileptiform activity
has been associated with transient episodes of amnestic
wandering and disorientation in AD (Rabinowicz et al.,uron 55, 697–711, September 6, 2007 ª2007 Elsevier Inc. 703
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Aberrant Excitatory Neuronal Activity in AD ModelsFigure 6. Ab-Dependent Alterations in the Dentate Gyrus Are
Associated with Increased Susceptibility of hAPPFAD Mice to
Seizures Induced by a GABAA Antagonist
Mice were injected i.p. with PTZ (40 or 80 mg/kg). Brain tissues were
collected 20 min thereafter, or earlier if they developed fatal seizures.
Behavior was video-recorded, and seizure severity was scored off-
line.
(A) Compared with NTG controls, hAPP-J20 mice had shorter latencies
to reach a given seizure severity (left), greater overall seizure severity
(center), and more seizure-associated deaths (right).
(B) hAPP-ARC48 mice and hAPP-J9/FYN mice also had increased
overall seizure severity compared with littermate controls.
(C) hAPP-J9/FYN mice also had a greater incidence of seizure-
associated death than the control groups.
(D) All NTG mice treated with 80 mg/kg of PTZ developed fatal seizure
activity.
(E–G) Protein levels of NPY (E), calbindin (F), and Fos (G) in the dentate
gyrus were not altered by fatal seizures.
(H–K) Compared with hAPP-J20 mice that survived the PTZ injection,
hAPP-J20 mice that developed fatal seizures had higher levels of NPY
in the dentate gyrus and mossy fibers (H), lower dentate calbindin levels
(I), and lower numbers of granule cells expressing Fos (J) or Arc (K).704 Neuron 55, 697–711, September 6, 2007 ª2007 Elsevier In2000). It is interesting in this regard that the relationship
between seizures and AD is even tighter in autosomal
dominant early-onset FAD. Pedigrees with epilepsy have
been identified in FAD linked to mutations in presenilin-
1, presenilin-2, and APP (Edwards-Lee et al., 2005; Mar-
con et al., 2004; Snider et al., 2005), as well as in FAD
linked to duplications of APP (Cabrejo et al., 2006). Over
30 different mutations in presenilin-1 are associated with
seizures (Larner and Doran, 2006), and 56% of FAD pa-
tients with APP duplications have seizures (Cabrejo
et al., 2006). Our results suggest that the increased epilep-
tic activity in sporadic and autosomal dominant AD may
be caused by Ab-induced increases in network excitabil-
ity. Although Ab may increase the incidence of seizures,
clinically evident convulsive seizure activity is not a prom-
inent feature in AD. Notably, our hAPPFAD mice had fre-
quent electroencephalographic seizures that were not
accompanied by obvious tonic-clonic movements, raising
the question of whether the extent of subclinical epileptic
activity in AD may be underestimated.
Generalized epileptic activity can trigger downstream
anatomical and molecular alterations in hippocampal cir-
cuits (Figures 7D and S2; Marksteiner et al., 1990; Tonder
et al., 1994b; Vezzani et al., 1999). Some of these alter-
ations have been characterized as compensatory inhibi-
tory mechanisms in different epileptic models, since they
can ameliorate neuronal overexcitation. hAPPFAD mice ex-
hibited a variety of such alterations in the dentate gyrus,
including altered levels of NPY receptors, ectopic NPY ex-
pression, GABAergic sprouting, and increased synaptic
inhibition. NPY-Y1 receptors, which were decreased in
hAPPFAD mice, typically reside on dendrites and mediate
weak excitatory effects of NPY (Vezzani et al., 1999).
NPY-Y1 receptor antagonists had anticonvulsive effects
in rat seizure models (Gariboldi et al., 1998). NPY-Y2 re-
ceptors, which were increased in hAPPFAD mice, typically
reside on presynaptic terminals and mediate strong pre-
synaptic inhibition of glutamate release via inactivation
of voltage-gated calcium channels (Qian et al., 1997;
Schwarzer et al., 1998). This inhibitory presynaptic mech-
anism of glutamate release would likely be augmented by
the ectopic expression of NPY in mossy fibers (Klapstein
and Colmers, 1993; Vezzani and Sperk, 2004). NPY and
particularly NPY-Y2 receptor agonists potently suppress
seizure activity in hippocampal slices in vitro and in exper-
imental animals in vivo (Baraban et al., 1997; Bijak, 1995;
Colmers et al., 1987; Smialowska et al., 1996; Vezzani
et al., 1999). Viral vector-mediated NPY expression in
the dentate gyrus of NTG rats inhibited seizure activity in-
duced by intrahippocampal kainate injection (Richichi
et al., 2004). We also found prominent GABAergic sprout-
ing and increases in mIPSC frequency and large ampli-
tude events in the dentate gyrus of hAPPFAD mice,
*p < 0.05, **p < 0.01, ***p < 0.001 versus NTG by Student’s t test or Tu-
key-Kramer test. #p < 0.05, ##p < 0.01 by Fisher’s exact test. Quantita-
tive data represent mean ± SEM.c.
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Aberrant Excitatory Neuronal Activity in AD ModelsFigure 7. Aberrant Synchronous Neuronal Network Activity and Spontaneous Nonconvulsive Seizures in hAPP-J20 Mice
Chronic cortical and hippocampal EEG recordings were performed in freely moving, untreated hAPP-J20 mice and NTG controls. L, left; R, right; F,
frontal; T, temporal; P, parietal; O, posterior-parietal; and H, hippocampal, indicate the position of recording electrodes.
(A) In contrast to NTG mice, which showed normal EEG activity (left), hAPP-J20 mice exhibited frequent (5–50/min) generalized cortical epileptiform
(interictal) spike discharges (right).
(B) Bilateral depth electrode recordings from the hippocampus detected occasional discharges of isolated hippocampal origin. In this example,
a prominent left-sided discharge remains focal with minimal spread to the neocortex.
(C) Initiation (upper panel) and termination (lower panel) of a cortical seizure in an hAPP-J20 mouse. Concurrent bilateral hippocampal depth electrode
recordings show abnormal synchronization beginning as spike discharges (arrowheads) in the hippocampus and overlying posterior-parietal neocor-
tex (LO-RO). Synchronous seizure activity then generalizes in the neocortex without behavioral signs of convulsive activity, followed by profound elec-
troencephalographic postictal depression. Calibration: 1 s and 400 mV.
(D) Model of Ab-induced network dysfunction. We propose that high levels of Ab induce aberrant excitatory neuronal activity, which triggers com-
pensatory inhibitory mechanisms to counteract overexcitation. Both aberrant excitatory neuronal activity and compensatory inhibitory mechanisms
may contribute to AD-related network dysfunction.indicating that GABAergic function is enhanced in this
brain region. Thus, most of the alterations we identified
in the dentate gyrus of hAPPFAD mice likely serve to coun-
teract Ab-induced neuronal overexcitation.
The tenuous balance between excitation and inhibition
in hAPPFAD mice was highlighted by our analysis of neuro-
nal Arc expression. Although Arc was reduced in most
hAPPFAD mice with high levels of Ab, consistent with
previous results (Palop et al., 2005), a small fraction of
hAPPFAD mice had markedly increased Arc expression in
the dentate gyrus, possibly reflecting recent breakthrough
seizure activity resulting from severe neuronal overexcita-
tion and/or relative inadequacies in synaptic inhibition.
Thus, the activity of granule cells in hAPPFAD mice,
and possibly also in humans with AD, may fluctuate be-
tween aberrant increases and postictal or compensatory
suppression.
In the current study, a single systemic injection of
kainate was sufficient to trigger prominent NPY/SOM-
positive sprouting and ectopic NPY expression in a distri-Neubution very similar to that observed in untreated hAPPFAD
mice. Similar alterations have been observed after electro-
convulsive seizures, electrical stimulation of the entorhinal
cortex, pharmacological stimulation of NMDA receptors
or metabotropic glutamate receptors, or inhibition of
GABA receptors (Marksteiner et al., 1990; Tonder et al.,
1994b), making it likely that aberrant increases in excit-
atory neuronal activity are the common underlying mech-
anism. It is interesting in this regard that kainate injection
also replicated several other Ab-induced dentate
alterations, including increases in the levels of STEP and
a7 nAChRs and reductions in calbindin and Arc (Chin
et al., 2005; Palop et al., 2003, 2005), suggesting that
the pathogenesis of these alterations in hAPPFAD mice
may also involve aberrant increases in neuronal activity.
Interestingly, hAPPFAD mice resemble models of
chronic temporal lobe epilepsy only in some respects,
but not in others. In contrast to chronic epilepsy models
(de Lanerolle et al., 1989; Nadler, 2003; Tu et al., 2006),
hAPPFAD mice showed no loss of NPY/SOM-positiveron 55, 697–711, September 6, 2007 ª2007 Elsevier Inc. 705
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citatory collateral mossy fibers in the inner molecular layer.
Instead, hAPPFAD mice showed sprouting of collateral
mossy fibers onto GABAergic basket cells. The circuit
alterations in the chronic epilepsy models would be
expected to promote hippocampal epileptogenesis,
whereas those in hAPPFAD mice should counteract it. Con-
sistent with this interpretation, synaptic inhibition in gran-
ule cells is largely compromised in models of epilepsy
(Kobayashi and Buckmaster, 2003; Shao and Dudek,
Figure 8. Alterations in Arc Expression and in NMDA and
AMPA Receptors in the Dentate Gyrus of hAPP-J20
Brain sections from 151 untreated hAPP-J20 mice and 142 NTG con-
trols were immunostained for Arc, calbindin, and NPY.
(A–C) Photomicrographs of the dentate gyrus showing three distinct
representative patterns of Arc expression we identified. (A) Normal
pattern of Arc expression found in virtually all NTG mice. (B) Typical re-
duction of Arc expression observed in the majority of hAPP-J20 mice.
(C) Roughly 9% of hAPP-J20 mice showed abnormally increased Arc
expression in the granule cells, suggestive of recent seizure activity.
(D and E) Calbindin depletions (D) and NPY increases (E) were even
more severe in hAPP-J20 mice with excessive Arc expression than
in hAPP-J20 mice with reduced Arc expression.
(F and G) Representative western blots of dentate lysates and quanti-
tations of signals illustrating reduced levels of tyrosine-phosphorylated
NR2B (pY1472), but not total NR2B levels (F), and reduced levels of
AMPA receptor subunits GluR1 and GluR2 (G) in hAPP-J20 mice com-
pared to NTG controls. Each lane represents an individual mouse.
**p < 0.01, ***p < 0.001 by Student’s t test. Quantitative data represent
mean ± SEM.706 Neuron 55, 697–711, September 6, 2007 ª2007 Elsevier In2005) but was significantly enhanced in hAPPFAD mice.
This difference may help explain why hAPPFAD mice had
primarily nonconvulsive seizures and why escalation of
epileptic activity into convulsive seizures is relatively infre-
quent in both hAPPFAD mice and humans with AD.
While the chronic activation of inhibitory mechanisms
can limit excitotoxic injury, it may also interfere with pro-
cesses required for learning and memory and other neural
functions (Figure 7D). Consistent with this idea, increased
inhibition of granule cells in a model of Down’s syndrome
caused LTP deficits in the dentate gyrus, as suggested
by the prevention of such deficits by treatment with the
GABAA antagonist picrotoxin (Kleschevnikov et al.,
2004). We found that increased inhibition and GABAergic
remodeling was also associated with deficits in short- and
long-term plasticity in the dentate gyrus of hAPPFAD mice.
However, LTP deficits were not normalized by picrotoxin
in hAPPFAD slices, suggesting additional pathogenic
mechanisms. Since depletion of calbindin (Molinari et al.,
1996), reduction of Arc expression (Guzowski et al., 2000),
and an increase of inhibition (Kleschevnikov et al., 2004)
can cause LTP deficits, and such alterations are present
in hAPPFAD mice (this study and Palop et al., 2003,
2005), it is likely that LTP impairments in hAPPFAD mice
have a multifactorial origin. The increased inhibition of
granule cells may underlie or contribute to the reduced
expression of immediate-early genes, such as Arc and
Fos, in the dentate gyrus of hAPPFAD mice (Chin et al.,
2005; Lee et al., 2004; Palop et al., 2003, 2005). It is inter-
esting in this regard that GABAergic sprouting correlated
with reductions in Arc (data not shown) and calbindin in
granule cells of hAPPFAD mice, which correlate well with
deficits in learning and memory (Palop et al., 2003,
2005). Because the experimental reduction of calbindin,
Fos, or Arc in otherwise healthy rodents elicits neuronal
deficits and memory impairments (Guzowski et al., 2000;
He et al., 2002; Molinari et al., 1996; Plath et al., 2006;
Tzingounis and Nicoll, 2006), the depletion of these factors
could further contribute to granule cell dysfunction and
behavioral deficits in hAPPFAD mice.
Notably, hAPPFAD mice showed impairments in both
synaptic glutamatergic transmission and levels of NMDAR
and AMPAR. Specifically, we showed reduced LTP and
paired-pulse modification, reduced phosphorylation of
the NMDAR subunit NR2B, and reduced levels of the AM-
PAR subunits GluR1 and GluR2 in the dentate gyrus of
hAPPFAD mice. These data are consistent with the growing
literature suggesting that Ab induces impairments in syn-
aptic glutamatergic transmission and retraction of excit-
atory dendritic spines (Hsia et al., 1999; Hsieh et al.,
2006; Kamenetz et al., 2003; Palop et al., 2005; Shankar
et al., 2007; Walsh et al., 2002). Therefore, aberrant in-
creases in neuronal activity in hippocampal and cortical
networks can coexist with impaired glutamatergic trans-
mission in hAPPFAD mice. Although the exact relationship
between these two phenomena needs to be further eluci-
dated, several non-mutually exclusive possibilities could
explain their coexistence. First, depressed glutamatergicc.
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Aberrant Excitatory Neuronal Activity in AD ModelsFigure 9. Region-Specific Electrophy-
siological Alterations in Hippocampal
Slices from hAPP-J20 Mice
(A) LTP at the medial perforant pathway syn-
apse within the dentate gyrus (DG) was signif-
icantly depressed in hAPP-J20 mice (6 slices,
6 mice) compared with NTG mice (9 slices,
8 mice; p < 0.01 by repeated-measures
ANOVA on data collected from minutes 51–60).
(B) At the medial or lateral (data not shown) per-
forant pathway, paired-pulse ratio, a common
measure of presynaptic function, was signifi-
cantly different in hAPP-J20 mice (15 slices,
7 mice) compared with NTG mice (15 slices,
8 mice; p < 0.01 by Student’s t test at all inter-
pulse intervals).
(C) The slope of the input-output relationship,
a measure of synaptic transmission, along the
medial or lateral (not shown) perforant pathway
was similar in hAPP-J20 (14 slices, 7 mice) and
NTG mice (12 slices, 7 mice).
(D) LTP at the Schaffer collateral synapse
within the CA1 region (CA1) was similar in
hAPP-J20 (5 slices, 5 mice) and NTG mice
(8 slices, 6 mice).
(E) Paired-pulse ratio at this synapse was similar in hAPP-J20 (14 slices, 6 mice) and NTG mice (16 slices, 7 mice).
(F) In contrast, synaptic transmission along the Schaffer collateral synapse was significantly less in hAPP-J20 mice (14 slices, 5 mice) than in NTG
mice (11 slices, 5 mice; p < 0.01 by ANCOVA).
TBS, theta-burst stimulation; HFS, high-frequency stimulation. Quantitative data represent mean ± SEM.transmission could be a synaptic compensatory mecha-
nism against overexcitation. Second, inhibitory interneu-
rons could be more susceptible to the suppressive effects
of Ab on glutamatergic synaptic transmission than excit-
atory principal neurons, leading to an overall increase in
neuronal excitability. Third, cortical or subcortical regions
that control neuronal excitability on a broad scale could be
particularly susceptible to Ab-induced impairments of
glutamatergic synaptic transmission, increasing overall
network excitability.
In conclusion, our findings suggest that Ab triggers in-
termittent aberrant excitatory neuronal activity in the cor-
tex and hippocampus, resulting in a prominent remodeling
of inhibitory circuits and increased inhibition of granule
cells. Thus, cognitive deficits in hAPPFAD mice, and per-
haps also in humans with AD, may result from the combi-
nation of neuronal overexcitation and the subsequent
development of compensatory inhibitory mechanisms
that reduce overexcitation but end up constraining the
functional agility of specific excitatory circuits. Studies
are needed to determine whether blocking Ab-induced
neuronal overexcitation can prevent the activation of




We studied 4- to 7-month-old heterozygous TG and NTG mice from
lines J20, J9, ARC48, I5, and N8, as well as J9/FYN doubly transgenic
mice and hAPP-J20/Tau/ mice. Lines J9 and J20 express hAPP car-
rying the Swedish and Indiana FAD mutations; line ARC48 expressesNehAPP carrying the Swedish, Indiana, and Arctic FAD mutations; line
I5 expresses wild-type hAPP; and line N8 overexpresses wild-type
mouse Fyn (Cheng et al., 2004; Chin et al., 2004, 2005; Dawson
et al., 2001; Mucke et al., 2000; Roberson et al., 2007). See Supple-
mental Experimental Procedures for more information.
Drugs
Pentylenetetrazole (PTZ) (Sigma), kainate (Sigma), and pilocarpine
(Tocris) were dissolved in PBS at 5, 1.8, and 20 mg/ml, respectively,
and injected intraperitoneally at the doses indicated in the Results
section.
Seizure Severity Score
After drug administration (PTZ, pilocarpine, or kainate), each mouse
was placed in a new cage and its behavior was videorecorded for
20 min or manually recorded for 3 hr for Tau-manipulated mice treated
with kainate. An investigator blinded to the genotype and treatment of
the mice quantified the time course and severity of seizures according
to published scales (Loscher et al., 1991; Racine, 1972). Seizure
severity scores were 0 = normal exploratory behavior, 1 = immobility,
2 = generalized spasm, tremble, or twitch, 3 = tail extension, 4 = fore-
limb clonus, 5 = generalized clonic activity, 6 = bouncing or running
seizures, 7 = full tonic extension, 8 = death.
Immunohistochemistry
Tissue preparation and immunohistochemistry were performed as de-
scribed (Palop et al., 2003, 2005). Primary antibodies used included
the following: rabbit anti-Arc (1:8000; a gift from S. Chowdhury and
P.F. Worley, Johns Hopkins University School of Medicine, Baltimore,
MD), rabbit anti-calbindin (1:15,000 for DAB; Swant), mouse anti-
calbindin (1:1000 for fluorescence; Swant), rabbit anti-Fos (1:10,000;
Ab-5, Oncogene), rabbit anti-neuropeptide Y (1:8000 for DAB,
1:4000 for fluorescent; ImmunoStar), rabbit anti-parvalbumin
(1:5000; Swant), rat anti-somatostatin (1:200 for DAB, 1:50 for fluores-
cence; Chemicon), or mouse biotinylated anti-Ab (1:400, 3D6; Elan
Pharmaceuticals). Primary antibodies were detected with biotinylateduron 55, 697–711, September 6, 2007 ª2007 Elsevier Inc. 707
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Aberrant Excitatory Neuronal Activity in AD Modelsgoat anti-rabbit (1:200; Vector Laboratories) or goat anti-rat (1:200;
Vector Laboratories) or with fluorescein-labeled donkey anti-rabbit
(1:300, Jackson ImmunoResearch), fluorescein-labeled goat anti-
rabbit (1:150; Vector Laboratories), Alexa Fluor 594 tyramide-labeled
goat anti-rat (1:300; Molecular Probes), or Texas red-labeled donkey
anti-mouse (1:300, Jackson ImmunoResearch).
Timm Staining
Sodium selenite (Sigma) was dissolved in PBS (10 mg/ml) and injected
i.p. at a dose of 20 mg/kg. Mice were sacrificed 1 hr after the injection.
Sliding microtome floating sections were processed for the detection
of vesicular zinc with a slightly modified Timm method. See Supple-
mental Experimental Procedures for details.
Quantitative Analysis of Brain Sections
Calbindin, Arc, and Fos were quantified as described (Palop et al.,
2003, 2005), and NPY was quantified similarly with a slight modifica-
tion (see Supplemental Experimental Procedures for details).
In Situ Hybridization and RT-PCR
For NPY in situ hybridization, antisense and sense cRNA probes were
generated from a linearized plasmid (IMAGE:5683102) containing full-
length NPY cDNA (561 bp) with T7 and T3 polymerase (Promega) and
premixed RNA-labeling nucleotide mixes containing digoxigenin
(Roche Molecular Biochemicals). For quantitative fluorogenic RT-
PCR analysis of mRNAs encoding NPY-Y1 or -Y2 receptors, the fol-
lowing primers were used: NPY-Y1, 50-CAGTGAGACCAAGCGAATC
AAC-30, 50-CTGGTGGTTCCAGTCGAACA-30; NPY-Y2, 50-TGGGCC
AGGGCACACTAC-30, 50-TCACCTGCACCTCGACCA-30. In situ hy-
bridization and RT-PCR were performed as described (Palop et al.,
2005).
Western Blot Analysis
Microdissections and western blot analysis was performed as de-
scribed (Chin et al., 2005; Palop et al., 2005). The following antibodies
were used and detected with species-appropriate horseradish perox-
idase-conjugated secondary antibodies: anti-a7 nAChR (1:1000;
mouse monoclonal, Covance), anti-calbindin (1:15,000; rabbit
polyclonal, Swant), anti-GluR1 and anti-GluR2 (1:20,000; rabbit poly-
clonals, Chemicon), anti-pY1472 (1:1000; rabbit polyclonal, Chemi-
con), anti-NR2B (1:10,000 rabbit polyclonal, Chemicon), and anti-
STEP (1:5000; mouse monoclonal, Novus Biologicals). Bands were
visualized by ECL and quantitated densitometrically with ImageQuant
software (Molecular Dynamics).
Electrophysiology
Transverse hippocampal slices (300 mm thick for mIPSC; 350 mm thick
for fEPSP) were prepared from 3- to 4-month-old NTG and hAPP-J20
mice. For more details see Supplemental Experimental Procedures.
mIPSC Recordings
NBQX (2 mM), D-AP5 (25 mM), and TTX (1 mM) were added to the exter-
nal solution to isolate miniature IPSCs. All recordings were performed
at room temperature. Whole-cell voltage-clamp recordings were ob-
tained from visualized hippocampal dentate gyrus granule cells using
IR-DIC video microscopy. Glass electrodes (3–4 MU) were filled with
a solution containing the following: 140 mM CsCl, 10 mM EGTA,
10 mM HEPES, 2 mM Mg-ATP, 0.3 mM Na-GTP (adjusted to pH 7.3
with CsOH). Access resistance and leak currents were monitored con-
tinuously and experiments were rejected if these parameters changed
by more than 15% during the experiment.
Voltage-clamp recordings were performed using a Multiclamp 700B
amplifier (Molecular Devices); data were filtered at 2 kHz and digitized
at 10 kHz. Acquisition and analysis were performed using custom Igor
Pro software.
fEPSP Recordings
Bipolar stimulating electrodes consisted of a glass microelectrode
(1020 mm OD) filled with bathing solution or 1 M NaCl and 25 mM708 Neuron 55, 697–711, September 6, 2007 ª2007 Elsevier IncHEPES (pH = 7.3). Stimulating electrodes were placed in the middle
of the outer or middle molecular layer of the dentate gyrus or in the mid-
dle of the stratum radiatum. Field potential recordings were obtained
using a MultiClamp 700A amplifier (Axon Instruments, Inc) controlled
by Axon’s pClamp 9. Recording pipettes had resistances of 2–4 MU
when filled with 1 M NaCl and 25 mM HEPES (pH = 7.3). The bathing
solution contained 100 mM picrotoxin and 20 mM bicuculline to block
inhibitory transmission and was perfused at 35C at approximately
2 ml/min. LTP was induced by high-frequency stimulation (HFS,
100 pulses at 100 Hz, four times in 20 s intervals) in CA1 or by theta-
burst stimulation (TBS, 10 bursts at 5 Hz, repeated 10 times in 15 s in-
tervals. Each burst consisted of four pulses of 100 Hz) in the dentate
gyrus. For data collection and analyses see Supplemental Experimen-
tal Procedures.
Chronic EEG Recordings
hAPP-J20 and NTG mice were implanted for chronic video-EEG mon-
itoring after anesthesia with Avertin (1.25% tribromoethanol/amyl alco-
hol solution, injected i.p. at 0.02 ml/g). Teflon-coated silver wire elec-
trodes (0.005 inch diameter) attached to a microminiature connector
were implanted bilaterally into the subdural space over frontal, central,
parietal, and occipital cortices. Simultaneous depth recordings were
also obtained from the hippocampal formation in two hAPP-J20
mice. Digital EEG activity was monitored daily for up to two weeks dur-
ing prolonged overnight and random 2 hr sample recordings (Stellate
Systems, Harmonie software version 5.0b). Recordings of similar dura-
tions were made in NTG and hAPP-J20 mice and were reviewed by an
investigator unaware of the genotypes of the mice. A video camera
was used to monitor behavior during the EEG recording periods. All re-
cordings were carried out at least 24 hr after surgery on mice freely
moving in the test cage.
Statistical Analysis
Statistical analyses were performed with SPSS 10.0 (SPSS). Unless in-
dicated otherwise, differences between two means were assessed by
unpaired, two-tailed Student’s t test and differences among multiple
means by ANOVA and Tukey-Kramer post hoc test. Differences be-
tween expected and observed frequencies were assessed by Fisher’s
exact test. Correlations were examined by simple regression analysis.
Null hypotheses were rejected at the 0.05 level.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/5/697/DC1/.
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